文献速递临床试验与 GCP基础与转化研究

基于行动的认知矫正对双相障碍认知与神经活动影响的随机对照试验方案

Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-09-12

该试验为随机、对照、平行组设计,计划招募58例18-55岁处于完全或部分缓解期且存在客观认知损害的双相障碍患者,随机接受10周基于行动的认知矫正(ABCR)或对照干预。主要结局为涵盖言语记忆、注意和执行功能的认知复合评分,并在基线和治疗2周时进行功能磁共振成像,探索背侧前额叶和海马神经活动的早期变化。

要点

  • ABCR可能改善缓解期双相障碍患者的认知与功能。
  • 主要结局为言语记忆、注意和执行功能的认知复合评分。
  • 功能磁共振聚焦背侧前额叶和海马早期神经活动变化。

核心结论

  • 该试验将探讨ABCR对缓解期双相障碍患者认知和功能是否有益,并探索与认知改善相关的早期神经活动变化。

研究设计与样本

  • 随机、对照、平行组试验,计划招募58例18-55岁处于完全或部分缓解期且存在客观认知损害的双相障碍患者。
  • 参与者随机接受10周ABCR或对照干预,评估在基线、治疗2周后、治疗结束时及治疗结束后6个月随访进行。
  • 功能磁共振扫描在基线和治疗2周时进行,主要结局为涵盖言语记忆、注意和执行功能的认知复合评分。

关键数值与推荐

  • 主要结局为涵盖言语记忆、注意和执行功能的认知复合评分。
  • 52例患者的两个完整数据集将提供80%的效能检测主要结局的临床相关组间差异。
  • 感兴趣区为背侧前额叶皮层和海马,并进行探索性全脑分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive impairment is present in bipolar disorder (BD) during the acute and remitted phases and hampers functional recovery. However, there is currently no clinically available treatment with direct and lasting effects on cognitive impairment in BD. We will examine the effect of a novel form of cognitive remediation, action-based cognitive remediation (ABCR), on cognitive impairment in patients with BD, and explore the neural substrates of potential treatment efficacy on cognition. METHODS/DESIGN: The trial has a randomized, controlled, parallel-group design. In total, 58 patients with BD in full or partial remission aged 18-55 years with objective cognitive impairment will be recruited. Participants are randomized to 10 weeks of ABCR or a control group. Assessments encompassing neuropsychological testing and mood ratings, and questionnaires on subjective cognitive complaints, psychosocial functioning, and quality of life are carried out at baseline, after 2 weeks of treatment, after the end of treatment, and at a six-month-follow-up after treatment completion. Functional magnetic resonance imaging scans are performed at baseline and 2 weeks into treatment. The primary outcome is a cognitive composite score spanning verbal memory, attention, and executive function. Two complete data sets for 52 patients will provide a power of 80% to detect a clinically relevant between-group difference on the primary outcome. Behavioral data will be analyzed using mixed models in SPSS while MRI data will be analyzed with the FMRIB Expert Analysis Tool (FEAT). Early treatment-related changes in neural activity from baseline to week 2 will be investigated for the dorsal prefrontal cortex and hippocampus as the regions of interest and with an exploratory whole-brain analysis. DISCUSSION: The results will provide insight into whether ABCR has beneficial effects on cognition and functioning in remitted patients with BD. The results will also provide insight into early changes in neural activity associated with improvement of cognition, which can aid future treatment development. TRIAL REGISTRATION: Clinicaltrials.gov , NCT03295305 . Registered on 26 September 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ott CV, Vinberg M, Bowie CR, et al. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30208971. doi:10.1186/s13063-018-2860-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。